![Neill Moray MacKenzie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Neill Moray MacKenzie
Chief Executive Officer at Trimunocor Ltd.
Network origin in Neill Moray MacKenzie first degree
Entity | Entity type | Industry | |
---|---|---|---|
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK
12
| Extinct | Pharmaceuticals: Major | 12 |
Biotecnol Ltd.
![]() Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom.
2
| Private Company | Biotechnology | 2 |
Biotecnol-Serviços e Desenvolvimento SA
![]() Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Neill Moray MacKenzie via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Phoqus Pharmaceuticals Plc
![]() Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Founder | |
University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal | |
Wellcome Plc
![]() Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Magdalen College School Oxford Ltd | College/University | Undergraduate Degree | |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oxagen Ltd.
![]() Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
University of Leeds | College/University | Doctorate Degree | |
Rhodes Trust | Director/Board Member | ||
University of Alberta | College/University | Undergraduate Degree | |
University of Bristol | College/University | Doctorate Degree | |
POSTNL N.V. | Air Freight/Couriers | Director/Board Member | |
Oxxon Therapeutics, Inc.
![]() Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Portuguese Catholic University | College/University | Corporate Officer/Principal | |
London Business School | College/University | Masters Business Admin | |
Academy of Medical Sciences
![]() Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | President | |
Associação Nacional de Jovens Empresários
![]() Associação Nacional de Jovens Empresários Miscellaneous Commercial ServicesCommercial Services Associação Nacional de Jovens Empresários provides enterprise development and business training for charity. It offers monitoring, advising, and mentoring. The company was founded in July 29, 1986 and is headquartered in Porto, Portugal. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
King's College London | College/University | Doctorate Degree | |
Heptares Therapeutics Ltd.
![]() Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Adaptimmune Ltd.
![]() Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Founder | |
Vida Rhein SA | Director/Board Member | ||
The Jenner Institute Laboratories
![]() The Jenner Institute Laboratories Miscellaneous Commercial ServicesCommercial Services The Jenner Institute Laboratories engages in the development of vaccine against major diseases. The company was founded in November 2005 and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Wellcome Trust Centre for Human Genetics | Founder | ||
Oxford Centre for Diabetes Endocrinology & Metabolism | Corporate Officer/Principal | ||
Oxford University Hospitals NHS Trust | Investment Trusts/Mutual Funds | Director/Board Member | |
The Gray Laboratory Cancer Research Trust | Director/Board Member | ||
The Oxford Health Alliance
![]() The Oxford Health Alliance Miscellaneous Commercial ServicesCommercial Services The Oxford Health Alliance is a British charitable company that focuses on preventing chronic diseases. The non-profit company is based in Greater London, UK. | Miscellaneous Commercial Services | Chairman | |
GMEC Management Co. Ltd. | Chairman | ||
The Ewelme Almshouse Charity | Director/Board Member | ||
Atopix Therapeutics Ltd.
![]() Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Genomics England Ltd.
![]() Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Office for Strategic Co-ordination of Health Research | Chairman | ||
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Director/Board Member | |
Microbiotica Ltd.
![]() Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
Biospring Management Partners LP
![]() Biospring Management Partners LP Investment ManagersFinance Biospring Management Partners LP (Biospring Partners) is a venture capital firm founded in 2020 by Michelle Dipp and Jennifer Lumba. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Chairman Founder | |
Our Future Health Uk
![]() Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam. | Miscellaneous Commercial Services | Director/Board Member | |
Associação Portuguesa de Bioindústrias | Founder | ||
Adaptimmune LLC
![]() Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | President | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder |
Statistics
International
United Kingdom | 33 |
United States | 9 |
Portugal | 5 |
Netherlands | 3 |
Canada | 3 |
Sectoral
Health Technology | 19 |
Consumer Services | 9 |
Commercial Services | 9 |
Transportation | 3 |
Health Services | 3 |
Operational
Director/Board Member | 75 |
Chairman | 24 |
Corporate Officer/Principal | 19 |
Chief Executive Officer | 12 |
Founder | 11 |
Most connected contacts
- Stock Market
- Insiders
- Neill Moray MacKenzie
- Company connections